Additionally, we noted a significantly robust inhibition of cell migration, invasion, and colony formation in CRC cells treated simultaneously with both drugs, whether expressing wt p53 or mutant p53, in comparison to the effect of either drug administered alone. Here, TP53 is linked to colorectal carcinoma.